Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Luzzi

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Disease|January 7, 2020
Outcomes and risk factors identification in urgent lung transplantation: a multicentric studyMarco Schiavon, Giulio Faggi, Lorenzo Rosso, et al.
Investigational New Drugs|December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesotheliomaIrene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
Frontiers in Oncology|September 27, 2021
Perioperative Outcome of Robotic Approach <i>Versus</i> Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)Giulia Veronesi, Abbas El-Sayed Abbas, Piergiorgio Muriana, et al.
Scandinavian Journal of Immunology|December 27, 2022
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseasesLaura Bergantini, Miriana d'Alessandro, Dalila Cavallaro, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Immune-inflammatory predictors of early and brain recurrence in young patients with resected non-small cell lung cancerDebora Brascia, Giuseppe Mangiameli, Maria Teresa Congedo, et al.
BMC Pulmonary Medicine|March 20, 2026
When BAL meets CT scan: enhancing noninvasive diagnosis of acute cellular rejection after lung transplantationElena Pordon, Marco Guerrieri, Felice Perillo, et al.
Journal of Clinical Medicine|August 14, 2025
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative ReviewCarola Pergolizzi, Chiara Lazzeri, Daniele Marianello, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Cell Death & Disease|October 17, 2020
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesotheliomaCaterina Costa, Paola Indovina, Eliseo Mattioli, et al.
Cell Death & Disease|September 15, 2020
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesotheliomaCaterina Costa, Paola Indovina, Eliseo Mattioli, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Disease|January 7, 2020
Outcomes and risk factors identification in urgent lung transplantation: a multicentric studyMarco Schiavon, Giulio Faggi, Lorenzo Rosso, et al.
Investigational New Drugs|December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesotheliomaIrene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
Frontiers in Oncology|September 27, 2021
Perioperative Outcome of Robotic Approach <i>Versus</i> Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)Giulia Veronesi, Abbas El-Sayed Abbas, Piergiorgio Muriana, et al.
Scandinavian Journal of Immunology|December 27, 2022
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseasesLaura Bergantini, Miriana d'Alessandro, Dalila Cavallaro, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Immune-inflammatory predictors of early and brain recurrence in young patients with resected non-small cell lung cancerDebora Brascia, Giuseppe Mangiameli, Maria Teresa Congedo, et al.
BMC Pulmonary Medicine|March 20, 2026
When BAL meets CT scan: enhancing noninvasive diagnosis of acute cellular rejection after lung transplantationElena Pordon, Marco Guerrieri, Felice Perillo, et al.
Journal of Clinical Medicine|August 14, 2025
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative ReviewCarola Pergolizzi, Chiara Lazzeri, Daniele Marianello, et al.
International Journal of Molecular Sciences|July 15, 2020
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Cell Death & Disease|October 17, 2020
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesotheliomaCaterina Costa, Paola Indovina, Eliseo Mattioli, et al.
Cell Death & Disease|September 15, 2020
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesotheliomaCaterina Costa, Paola Indovina, Eliseo Mattioli, et al.
Pageof 10